Emmessar Biotech & Nutrition Ltd — Quarterly Results & Earnings

₹23.56

+0.17%

Profit Growth YoY-60.71%Latest quarter

Sales Growth YoY-73.53%Latest quarter

Sales CAGR 5Y-29.08%5 year compound

Profit CAGR 5Y-19.73%5 year compound

📋

Quarterly Performance

YoY Profit Growth-60.71%

🔴 Significant decline

YoY Sales Growth-73.53%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

-29.14%

EPS Growth 5Y

-19.73%

Interest Coverage

Higher = safer debt servicing

N/A

ROE

4.23%

ROCE

12.61%

💡

Growth Analysis

Emmessar Biotech & Nutrition Ltd reported YoY profit growth of -60.71% and revenue growth of -73.53% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at -29.08% and profits at -19.73% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Emmessar Biotech & Nutrition Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Commodity Chemicals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.